Pre-Approval Required
None
Supplemental Information or Form
- Pure,
viable subculture of an isolate from a sterile body
source
- Completed
submittal form with 2 patient identifiers (e.g. name and date of birth),
collection date and source, a brief but complete patient history, cultural
history and submitting laboratoryās findings
- Documentation that indicates the role of this isolate in clinical
disease
- Form LAB 446
Performed on Specimens From
None
Acceptable Sample/Specimen Type for Testing
Confirmed
or suspected Neisseria meningitidis isolate
Minimum Volume Required
None
Storage & Preservation of Sample/Specimen Prior to Shipping
None
Transport
Tubed
agar medium with a secure screw cap, labeled with patientās name
Sample/Specimen Labeling
None
Shipping Instructions which Include Specimen Handling Requirements
- Grow
isolate under appropriate conditions prior to shipping.
- Ship
at ambient temperature using appropriate DOT/IATA approved shipping
procedures.
Test Methodology
As
needed - Biochemical testing, Serogrouping by slide agglutination or, if
appropriate, by an in-house validated PCR procedure, Gene Sequencing by PCR,
and/ or MALDI-TOF mass spectrometry. Please note that serogrouping will only
be performed on isolates from sterile body sites, such as blood or cerebrospinal
fluid, that have been confirmed as Neisseria meningitidis.
Turnaround Time
One week
Interferences & Limitations
Mixed
or nonviable culture
Additional Information
Please
contact the MDL Vaccine
Preventable Pathogens & Molecular Bacteriology Unit (VPP & MBU) for special consideration if any of the above
criteria cannot be met.
MDL Points of Contact
VPP & MBU Unit: (510) 412-3700
Monday-Friday
8 AM to 5 PM PT
Email: MDL.Submissions@CDPH.ca.gov